Comparison of pathways associated with hepatitis B- and C-infected hepatocellular carcinoma using pathway-based class discrimination method (Q42980168)

12 November 2017

title

Comparison of pathways associated with hepatitis B- and C-infected hepatocellular carcinoma using pathway-based class discrimination method (English)

1 reference

12 November 2017

main subject

hepatocellular carcinoma

1 reference

3

1 reference

12 November 2017

Sun Young Lee

1

1 reference

12 November 2017

Kwang Hoon Song

2

1 reference

12 November 2017

Kee-Ho Lee

4

1 reference

12 November 2017

Kyung-Suk Suh

5

1 reference

12 November 2017

Bu-Yeo Kim

6

1 reference

12 November 2017

publication date

29 April 2012

1 reference

12 November 2017

1 reference

12 November 2017

volume

99

1 reference

12 November 2017

issue

6

1 reference

12 November 2017

page(s)

347-354

1 reference

Global cancer statistics, 2002

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Chronic hepatitis in multiple virus infection: histopathological evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Differential gene expression between chronic hepatitis B and C hepatic lesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Different signaling pathways in the livers of patients with chronic hepatitis B or chronic hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Differential gene expression in distinct virologic types of hepatocellular carcinoma: association with liver cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Distinct expression patterns in hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Feature genes of hepatitis B virus-positive hepatocellular carcinoma, established by its molecular discrimination approach using prediction analysis of microarray

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Predicting the prognosis of hepatocellular carcinoma using gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Comparative study of gene set enrichment methods.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Gene set enrichment analysis provides insight into novel signalling pathways in breast cancer stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Deciphering the genetic landscape of cancer--from genes to pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Molecular pathways in tumor progression: from discovery to functional understanding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Incorporating prior knowledge of predictors into penalized classifiers with multiple penalty terms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Sparse linear discriminant analysis for simultaneous testing for the significance of a gene set/pathway and gene selection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Pathway analysis using random forests classification and regression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Building pathway clusters from Random Forests classification using class votes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Diagnosis of multiple cancer types by shrunken centroids of gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Viral hepatitis and liver cancer: the case of hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Evidence of aberrant lipid metabolism in hepatitis C and hepatocellular carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Activation of the unfolded protein response and autophagy after hepatitis C virus infection suppresses innate antiviral immunity in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Pathogenesis of hepatitis B virus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Hepatitis B virus core promoter mutations contribute to hepatocarcinogenesis by deregulating SKP2 and its target, p21

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Aberrant splicing of Hugl-1 is associated with hepatocellular carcinoma progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Hepatitis B and C virus-related carcinogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Transforming growth factor-β adaptor, β2-spectrin, modulates cyclin dependent kinase 4 to reduce development of hepatocellular cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Mitogen-activated protein kinases in hepatocellular carcinoma development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Expression of gap junction protein connexin32 in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Expression of tight junction protein claudin-5 in tumor vessels and sinusoidal endothelium in patients with hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Distinct temporospatial expression patterns of glycolysis-related proteins in human hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Proteomic analysis of beta-catenin activation in mouse liver by DIGE analysis identifies glucose metabolism as a new target of the Wnt pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

KEGG for linking genomes to life and the environment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

Reactome knowledgebase of human biological pathways and processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2012.04.004

10.1016/J.YGENO.2012.04.004

7 January 2021

Identifiers

DOI

1 reference

12 November 2017

1 reference